Aignostics Announces Early Access for Atlas H&E-TME

Aignostics is excited to announce early access to Atlas H&E-TME, a self-service tool for comprehensive analysis of the tumor microenvironment (TME) in H&E images at single-cell resolution. 

Atlas H&E-TME provides deep insights about spatial biology across 16 cancer subtypes. The product is built using Atlas – the foundation model we co-developed with Mayo Clinic and Charité Berlin – under ISO 13485-certified design control quality standards. Whole-slide images are fully analyzed in just a few hours, with a range of readouts including:

• Qualitative polygon overlays for tissue QC, tissue segmentation, cell detection, and cell classification
• Over 5,000 quantitative spatial metrics, including cell, tissue, and neighborhood-level features

Model performance has been extensively validated for each cancer type and our Performance Assurance Guarantee ensures that results meet your standards. Available via our easy-to-use API, Atlas H&E-TME empowers researchers with deeper, more scalable insights from every H&E image. 

Reach out to learn about getting a free trial as part of our early access program: https://www.aignostics.com/products/he-tme-profiling-product#form.